Mining & Metals
Diagnos Submits Modified And Updated Application to Health Canada For CARA Platform
Diagnos (ADK.V) has submitted a modified and updated application for a Class II medical device licence for its CARA System platform to Health Canada, the company said on Tuesday.The revised application follows detailed guidance from Health Canada last year.By integrating image enhancement and an interpretability tool directly into the clinical workflow, CARA delivers detailed analytical insights that support clinical findings during comprehensive examinations, ensuring practitioners always remain the final authority on patient care, a statement said.Diagnos shares were last seen unchanged at $0.195 on the TSX Venture Exchange.
$ADK.V
